Keeping in mind that phenotype switching in melanoma cells entails the exclusive expression of β-catenin cofactors LEF1 or TCF7L2 [60], we interrogated whether SPARC can be integrated into this process, either in the presence or absence of PRRX1 expression. Here, SPARC is linked to melanoma.